Antikörper

Suchziel:
?
?
Verknüpfung:
Suche nach:

Kontakt | Druckansicht | PDF-Ansicht | Antikörper weiterempfehlen

AbD Serotec - a Division of MorphoSys AG

RABBIT ANTI 14-3-3 ZETA

AHP1052 recognizes the acetylated N-terminal of 14-3-3 zeta in all mammals. It is a member of the 14-3-3 family which consists of 30kDa proteins that are involved in multiple protein kinase signaling pathways, regulation of cell cycle progression, cytoskeletal structure, transcription, intracellular trafficking and targeting. Protein interactions with 14-3-3 show distinct preference for its different isotypes and are regulated by phosphorylation of both 14-3-3 and the bound protein. 14-3-3 zeta is a susceptibility gene for paranoid schizophrenia and is overexpressed in the temporal cortex of cognitively impared Alzheimers patients. The protein binds yeast Sps1/Ste20-related kinase 1 (YSK1) and localizes to the golgi, possibly linking YSK1 signaling, protein transport, cell adhesion and migration. It co-localizes with epidermal growth factor receptor to the plasma membrane following epidermal growth factor signaling. The zeta isoform is involved in MAPKAPK2-mediated phosphorylation which may have a role in p38 MAPK-dependent inflammation. When bound to ADAM 22, 14-3-3 zeta is involved in cell adhesion. 14-3-3 zeta also interacts with cofilin, LIM-domain-containing protein kinase 1, protein kinase B/Akt and GPI alpha. AHP1052 may not react with recombinant proteins that are not N-acetylated.

Anbieter:  AbD Serotec
Datenblatt:  Datenblatt
Bestellnummer:  AHP1052
Klon Typ:  Polyclonal Antibody
Anwendung:  P*, E, WB
Reaktivität:  Sheep
Antigen:  14-3-3 ZETA
Host:  Rabbit
Format:  Serum
Immunogen:  Synthetic peptide corresponding to acetylated N-terminal sequence of sheep 14-3-3 zeta. Peptide sequence: Ac.MDKNELVQKAC
Menge:  0.1 ml
  Zur Webseite des Anbieters
Kontakt / Infos anfordern
Weitere Informationen

AbD Serotec - a Division of MorphoSys AG
Martinsried/Planegg, Deutschland

News
-  15.02.2007 - AbD Serotec und Thermo Fisher Scientific unterzeichnen Technologie-Vereinbarung
 
MyBionity.COM
Newsletter-Abo
Ihre e-Mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET